Briefing: Cancer cells can ‘barf’ proteins onto their cell surface, creating new targets for immunotherapies
Strategic angle: An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors.
A recent study has revealed that cancer cells can express proteins on their cell surfaces, a process described as 'barfing' proteins. This unexpected mechanism could have significant implications for immunotherapy development.
The discovery suggests that these surface proteins may serve as novel targets for therapeutic intervention, particularly in solid tumors where effective targets have been historically challenging to identify.
As researchers explore this mechanism further, the potential for improved immunotherapy strategies could reshape treatment paradigms in oncology, enhancing the efficacy of existing therapies.